Open: 0.0 Close: 0.0 Change: 0.0

Today's Summary

ionis pharmaceuticals (ions) stock surges on promising hepatitis b drug trial results. capricorn buys new stake in ions with 163,000 shares | the motley fool. a securities and exchange commission filing dated October 17, 2025 reported a new position in Ionis Pharmaceuticals.rebuttal to right-wing anti-obama revisionism should be the same as retal to left-wing version. remark to right wing anti obamas revisionist policy should be same as left-handed version - he was good president.